Killing by breaking the wall
Most drugs work by fitting into a specific target, like a key into a lock. A particular family of peptides works much more bluntly. They attack the membrane that surrounds a cell, and punch holes in it.
That family appears in two very different places in Peptide Nano-Chemistry and Nanotechnology: as antibiotics (Chapter 12) and as experimental anticancer agents (Chapter 1 and others). It turns out the same physical principle can be aimed at both.
Why charge matters
The key is electric charge. The outer surface of bacterial membranes carries a strong negative charge. Healthy human cells, on their outer surface, are closer to neutral.
Many membrane-attacking peptides are positively charged (rich in lysine and arginine) and amphipathic: one face of the molecule is oily, the other is charged. Positive charge draws them to negatively charged membranes. The oily face then pushes into the membrane's fatty interior. Enough of them, and the membrane is disrupted.
Chapter 12 notes that most natural antimicrobial peptides carry a net positive charge between +2 and +11, and that roughly half their residues are hydrophobic.
Designed to be selective
Chapter 1 gives a nice example of design. Researchers made a series of short peptides with the pattern G(IIKK)nI-NH2, varying n from 2 to 4. The repeating IIKK unit alternates oily isoleucines with positively charged lysines.
When the peptide meets a bacterial membrane, it folds from a floppy chain into an α-helix, with its isoleucines on one side and lysines on the other, and disrupts the membrane. The chapter reports that by tuning the number of repeats, the researchers found the version with the best selectivity: strong antibacterial action with low toxicity to normal cells. The end caps (a glycine at the start, an amide at the end) improved helix stability and resistance to enzymes.
Three ways to break a membrane
Chapter 12 describes several models for how these peptides destroy membranes. Three are the most important.
Barrel-stave. Peptides line up side by side and insert straight through the membrane, forming a ring like the staves of a barrel. Their oily faces touch the membrane interior, and their charged faces line a water-filled pore. The chapter associates this with the peptide alamethicin.
Toroidal pore (or wormhole). The peptides insert along with the membrane lipids themselves, bending the membrane so that the pore is lined partly by peptide and partly by lipid heads. The chapter associates this with magainin, from frog skin, and with melittin, from bee venom. It notes magainin needs roughly one peptide for every 30 lipids before this kicks in.
Carpet. The peptides lie flat on the membrane surface, covering it like a carpet, until they reach a threshold concentration, then disrupt the membrane like a detergent, breaking it into fragments. The chapter lists cecropin and the human peptide LL-37 among those thought to act this way.
Turning the same idea on cancer
Here is where it connects to cancer. Cancer cells often display more negatively charged molecules on their outer surface than healthy cells. That makes them somewhat more attractive to positively charged, membrane-attacking peptides.
Chapter 1 describes a well-known example: the peptide KLAKLAKKLAKLAK, usually called KLAK. It forms a charged, amphipathic helix. The chapter describes it as specifically destroying the membranes of cancer cells at low concentration. Researchers combined it with hyaluronic acid, which cancer cells tend to bind and break down, to build membranes for drug delivery and cancer therapy.
Another chapter 1 example, the anticancer peptide PTP-7 (FLGALFKALSKLL), was modified by adding two amino acids in different positions, producing versions that formed fibres or micelles with improved stability in serum.
Why membrane attack is attractive
The chapters make the case clearly. Conventional antibiotics usually hit one specific target: an enzyme that builds the cell wall, a ribosome that makes proteins. A single mutation in that target can make a bacterium resistant.
Membrane attack is harder to escape. Changing the whole makeup of your membrane is a big evolutionary ask. Chapter 12 says the distinct killing mechanisms of these peptides reduce the likelihood of resistance and cross-resistance.
The catch
The same bluntness that makes membrane attack hard to resist also makes it hard to control. The difference in charge between bacterial or cancer cell membranes and healthy human cell membranes is real, but it is a difference of degree. At high enough concentrations, many of these peptides damage human cells too. Red blood cells are a common casualty in testing (the word is haemolysis).
Chapter 12's own history section includes a telling example: tyrocidine, discovered in 1941, had broad antimicrobial activity but was toxic to human blood cells. Melittin, from bee venom, is a powerful membrane disruptor and a poor candidate for injection for exactly that reason.
That is why the design work matters so much. Finding the version, like the IIKK series above, that maximises the gap between killing the target and harming the host, is most of the challenge.
Why this matters to you
Membrane-attacking peptides are one of nature's oldest defence systems. Your own skin and immune cells make LL-37. Frogs coat their skin with magainins. Insects make cecropins. Understanding how they work explains why they are such a hopeful direction against antibiotic resistance, and why turning them into safe medicines has proven so hard. Part 6 looks at the antibiotic story in more detail.
This series explains biomedical research for general readers. Most approaches described are at the laboratory or animal study stage and are not available treatments. Nothing here is medical advice.
